Cited by 55

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides

Wolf-Levy, Hila, Javitt, Aaron, Eisenberg-Lerner, Avital, Kacen, Assaf, Ulman, Adi, Sheban, Daoud, Dassa, Bareket, Fishbain-Yoskovitz, Vered, Carmona-Rivera, Carmelo, Kramer, Matthias P, Nudel, Neta, Regev, Ifat, Zahavi, Liron, Elinger, Dalia, Kaplan, Mariana J, Morgenstern, David, Levin, Yishai, Merbl, Yifat·2018·Nature Biotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt.4279

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 40

  1. Rock, K.L. et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761–771 (1994). · DOI · Paper page
  2. Schmidt, M. & Finley, D. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta 1843, 13–25 (2014). · DOI
  3. Hershko, A. & Ciechanover, A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61, 761–807 (1992). · DOI
  4. Finley, D., Chen, X. & Walters, K.J. Gates, channels, and switches: elements of the proteasome machine. Trends Biochem. Sci. 41, 77–93 (2016). · DOI
  5. Rock, K.L., York, I.A., Saric, T. & Goldberg, A.L. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80, 1–70 (2002). · DOI
  6. Rock, K.L., Reits, E. & Neefjes, J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 37, 724–737 (2016). · DOI · Paper page
  7. Rape, M. & Jentsch, S. Taking a bite: proteasomal protein processing. Nat. Cell Biol. 4, E113–E116 (2002). · DOI
  8. Yen, H.-C.S., Xu, Q., Chou, D.M., Zhao, Z. & Elledge, S. J. Global protein stability profiling in mammalian cells. Science 322, 918–923 (2008). · DOI · Paper page
  9. Savitski, M.M. et al. Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis. Cell 173, 260–274.e25 (2018). · DOI
  10. Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325–340 (2011). · DOI
  11. Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 689 (2018). · DOI
  12. McShane, E. et al. Kinetic analysis of protein stability reveals age-dependent degradation. Cell 167, 803–815.e21 (2016). · DOI
  13. Eden, E. et al. Proteome half-life dynamics in living human cells. Science 331, 764–768 (2011). · DOI
  14. Mann, M. & Kelleher, N.L. Precision proteomics: the case for high resolution and high mass accuracy. Proc. Natl. Acad. Sci. USA 105, 18132–18138 (2008). · DOI · Paper page
  15. Larance, M., Ahmad, Y., Kirkwood, K.J., Ly, T. & Lamond, A.I. Global subcellular characterization of protein degradation using quantitative proteomics. Mol. Cell. Proteomics 12, 638–650 (2013). · DOI
  16. Cardozo, C., Vinitsky, A., Hidalgo, M.C., Michaud, C. & Orlowski, M. A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex. Biochemistry 31, 7373–7380 (1992). · DOI
  17. Nussbaum, A.K. et al. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc. Natl. Acad. Sci. USA 95, 12504–12509 (1998). · DOI
  18. Zhou, F. et al. Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat. Commun. 4, 2171 (2013). · DOI
  19. Feist, E., Burmester, G.-R. & Krüger, E. The proteasome: victim or culprit in autoimmunity. Clin. Immunol. 172, 83–89 (2016). · DOI
  20. Ullrich, O. et al. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. USA 96, 6223–6228 (1999). · DOI
  21. Cervantes-Laurean, D., Roberts, M.J., Jacobson, E.L. & Jacobson, M.K. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment. Free Radic. Biol. Med. 38, 786–795 (2005). · DOI
  22. Wang, C.H., Wu, S.B., Wu, Y.T. & Wei, Y.H. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp. Biol. Med. (Maywood) 238, 450–460 (2013). · DOI
  23. Cadenas, E. & Davies, K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29, 222–230 (2000). · DOI · Paper page
  24. Kisselev, A.F., Kaganovich, D. & Goldberg, A.L. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes: evidence for peptide-induced channel opening in the alpha-rings. J. Biol. Chem. 277, 22260–22270 (2002). · DOI
  25. Schmidtke, G., Emch, S., Groettrup, M. & Holzhütter, H.-G. Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome. J. Biol. Chem. 275, 22056–22063 (2000). · DOI
  26. Liepe, J. et al. Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes. eLife 4, e07545 (2015). · DOI
  27. Murakami, Y. et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360, 597–599 (1992). · DOI
  28. Vlashi, E. et al. In vivo imaging, tracking, and targeting of cancer stem cells. J. Natl. Cancer Inst. 101, 350–359 (2009). · DOI
  29. Philips, G.K. & Atkins, M. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies. Int. Immunol. 27, 39–46 (2015). · DOI
  30. Yang, W., Chen, P.W., Li, H., Alizadeh, H. & Niederkorn, J.Y. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro. Invest. Opthalmol. Vis. Sci. 49, 2518–2525 (2008). · DOI
  31. Tan, E.M. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271–1277 (1982). · DOI · Paper page
  32. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008). · DOI · Paper page
  33. Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L.J. & Mann, M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteomics 14, 658–673 (2015). · DOI
  34. Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016). · DOI · Paper page
  35. Mi, H. et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33, D284–D288 (2005). · DOI
  36. Ruepp, A. et al. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res. 36, D646–D650 (2008). · DOI
  37. Ruepp, A. et al. CORUM: the comprehensive resource of mammalian protein complexes--2009. Nucleic Acids Res. 38, D497–D501 (2010). · DOI
  38. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003). · DOI · Paper page
  39. You, Y., Jang, I., Lee, K., Kim, H. & Lee, K. An approach for a substitution matrix based on protein blocks and physicochemical properties of amino acids through PCA. Interdiscip. Bio Cent. 6, 3.1–3.10 (2014). · DOI
  40. Vizca&no, J.A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, D447–D456 (2016). · DOI

Cited by

Sorted by citations

Metadata

Authors
Wolf-Levy, H., Javitt, A., Eisenberg-Lerner, A., Kacen, A., Ulman, A., Sheban, D., Dassa, B., Fishbain-Yoskovitz, V., Carmona-Rivera, C., Kramer, M. P., Nudel, N., Regev, I., Zahavi, L., Elinger, D., Kaplan, M. J., Morgenstern, D., Levin, Y., & Merbl, Y.
Venue
Nature Biotechnology
Published
2018-10-22
Volume
36
Issue
11
Pages
1110-1116
ISSN
  • 1087-0156
  • 1546-1696
Cited by
55
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review